Eli Lilly and Company (LLY)
XETR
Real-time Data
07:00 AM
Day's Range
1,050.0052 wk Range
596.30Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
866.17B
P/E (Trailing)
‪42.39‬
P/E (Forward)
‪153.14‬
PEG Ratio
‪1.61‬
Price / Sales (TTM)
‪12.14‬
Price / Book
‪33.35‬
EV / EBITDA
‪24.30‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪1,027.06‬
200-Day Avg
‪910.03‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly and Company
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
- LLYXETREli Lilly and Company967.83BMarket Cap+44.68%52-week change42.40P/E (Trailing)‪33.52%‬Profit Margin
- JNJXETRJohnson & Johnson560.78BMarket Cap+34.27%52-week change31.45P/E (Trailing)‪21.48%‬Profit Margin
- 4ABXETRAbbVie Inc.403.07BMarket Cap+21.79%52-week change74.52P/E (Trailing)‪9.80%‬Profit Margin
- 6MKXETRMerck & Co., Inc.324.08BMarket Cap+44.20%52-week change120.52P/E (Trailing)‪4.76%‬Profit Margin
- RHOXETRRoche Holding AG323.64BMarket Cap+28.61%52-week change24.90P/E (Trailing)‪19.60%‬Profit Margin
- NOTXETRNovartis AG259.02BMarket Cap+20.99%52-week change23.66P/E (Trailing)‪22.50%‬Profit Margin
- ZEGXETRAstraZeneca PLC249.22BMarket Cap+14.75%52-week change28.34P/E (Trailing)‪17.02%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing prescription medicines for human health. Headquartered in Indianapolis, Indiana, and founded in 1876, the company operates in therapeutic areas that include diabetes, obesity, oncology, immunology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
